Wealth Enhancement Advisory Services, LLC Igm Biosciences, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 11,584 shares of IGMS stock, worth $15,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,584Holding current value
$15,985% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
83Shares Held
19.4MCall Options Held
61.3KPut Options Held
36.7K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.65 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$4.93 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.6 Million0.9% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$4.07 Million1.41% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.35 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $40M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...